Related Experiment Video
Updated: May 22, 2026
Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice
Published on: October 6, 2023
Mesenchymal stem cells for retinal diseases
1Fujian Institute of Ophthalmology, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian Province, China.
Abstract:
Retinal diseases are featured with the common result of retinal cell apoptosis that will cause irreversible vision loss. Various attempts have been made for the solution against cell death. However, few approaches turn out to be effective. With the progress in mesenchymal stem cells (MSCs) research, MSCs were considered as a promising source for cell replacement or neuroprotection in retinal disorders. MSCs have the property of self-renewal and are multipotent cells derived from various mesenchymal tissues, which were demonstrated being capable of differentiating into multilineage tissue cells. Some works were also done to differentiate MSCs into retinal cells. MSCs could be induced to express retinal cell markers under certain stimuli. Recent studies also suggest that MSCs should be an ideal source for neuroprotection via the secretion of a variety of neurotrophins. Engineered MSCs were also used as vehicles for continuous delivery of neurotrophins against retinal degeneration with encouraging results. Since there are still barriers on the differentiation of MSCs into functional retinal cells, the use of MSCs for neuroprotection in retinal diseases seems to be a more practicable approach and worthy of further investigations.
Insights
Mesenchymal stem cells (MSCs) offer potential for treating retinal diseases by protecting cells from death. While direct retinal cell differentiation remains challenging, MSCs show promise for neuroprotection against vision loss.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Cell Biology
Background:
- Retinal diseases often lead to irreversible vision loss due to retinal cell apoptosis.
- Current therapeutic strategies for retinal cell death have limited effectiveness.
- Mesenchymal stem cells (MSCs) are multipotent cells with self-renewal properties, showing promise in regenerative medicine.
Purpose of the Study:
- To explore the potential of mesenchymal stem cells (MSCs) in addressing retinal cell apoptosis and vision loss.
- To evaluate MSCs as a source for cell replacement or neuroprotection in retinal disorders.
- To investigate the feasibility of using MSCs for neuroprotection given challenges in their differentiation into functional retinal cells.
Main Methods:
- Reviewing existing research on MSCs and their application in retinal disorders.
- Analyzing the potential of MSCs to differentiate into retinal cells under specific stimuli.
- Examining the neuroprotective capabilities of MSCs through the secretion of neurotrophins.
- Assessing the use of engineered MSCs for sustained neurotrophin delivery.
Main Results:
- MSCs can be induced to express retinal cell markers, though functional differentiation remains a barrier.
- MSCs secrete various neurotrophins, suggesting a strong potential for neuroprotection.
- Engineered MSCs have demonstrated encouraging results in delivering neurotrophins to combat retinal degeneration.
Conclusions:
- Mesenchymal stem cells (MSCs) represent a promising therapeutic avenue for retinal diseases.
- Neuroprotection via MSCs is a more practicable approach than direct cell replacement due to differentiation challenges.
- Further investigation into MSC-based neuroprotection is warranted for treating retinal degeneration and preventing vision loss.
Related Concept Videos
01:19Mesenchymal Stem Cells
01:22iPS Cell Differentiation
01:13Induced Pluripotent Stem Cells
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...